An individualized immune prognostic signature in lung adenocarcinoma

被引：0
|
作者：
Liangdong Sun
Gening Jiang
Diego Gonzalez-Rivas
Peng Zhang
机构：
[1] Tongji University School of Medicine,Department of Thoracic Surgery, Shanghai Pulmonary Hospital
[2] The First Affiliated Hospital of Wenzhou Medical University,Department of Thoracic Surgery
来源：
Cancer Cell International | / 20卷
关键词：
Lung adenocarcinoma; Immune risk score; Immune clinical score; Prognosis; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma
    Pancheng Wu
    Yi Zheng
    Yanyu Wang
    Yadong Wang
    Naixin Liang
    Journal of Translational Medicine, 18
  • [32] Prognostic and immune implications of a novel ferroptosis-related ten-gene signature in lung adenocarcinoma
    Ma, Chao
    Li, Feng
    Luo, Huan
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (13)
  • [33] Development and validation of a tumor microenvironment-related prognostic signature in lung adenocarcinoma and immune infiltration analysis
    Zhou Li
    Yanqi Feng
    Piao Li
    Shennan Wang
    Ruichao Li
    Shu Xia
    Oncology and Translational Medicine, 2021, 7 (06) : 253 - 268
  • [34] Ferroptosis-Related Genes in Lung Adenocarcinoma: Prognostic Signature and Immune, Drug Resistance, Mutation Analysis
    Ren, Ziyuan
    Hu, Minghui
    Wang, Zhonglin
    Ge, Junpeng
    Zhou, Xiaoyan
    Zhang, Guoming
    Zheng, Hongying
    FRONTIERS IN GENETICS, 2021, 12
  • [35] Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma
    Zhang, Lemeng
    Luo, Yongzhong
    Cheng, Tianli
    Chen, Jianhua
    Yang, Hua
    Wen, Xiaoping
    Jiang, Zhou
    Li, Haitao
    Pan, Changqie
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2021, 14 : 1549 - 1563
  • [36] Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
    Cheng, Yang
    Hou, Kezuo
    Wang, Yizhe
    Chen, Yang
    Zheng, Xueying
    Qi, Jianfei
    Yang, Bowen
    Tang, Shiying
    Han, Xu
    Shi, Dongyao
    Wang, Ximing
    Liu, Yunpeng
    Hu, Xuejun
    Che, Xiaofang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [37] Four-miRNA signature as a prognostic tool for lung adenocarcinoma
    Lin, Yan
    Lv, Yufeng
    Liang, Rong
    Yuan, Chunling
    Zhang, Jinyan
    He, Dan
    Zheng, Xiaowen
    Zhang, Jianfeng
    ONCOTARGETS AND THERAPY, 2018, 11 : 29 - 36
  • [38] Identification of a Thirteen-Gene Prognostic Signature for Lung Adenocarcinoma
    Wang, Y.
    Wo, Y.
    Lu, T.
    Jiao, W.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S523 - S524
  • [39] A prognostic signature model for unveiling tumor progression in lung adenocarcinoma
    Li, Zijian
    Zeng, Tao
    Zhou, Chong
    Chen, Yan
    Yin, Wu
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [40] Identification of an eight-gene prognostic signature for lung adenocarcinoma
    Li, Shicheng
    Xuan, Yunpeng
    Gao, Bing
    Sun, Xiao
    Miao, Shuncheng
    Lu, Tong
    Wang, Yuanyong
    Jiao, Wenjie
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 3383 - 3392
12345